Tower Research Capital (TRC)’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $701K | Buy |
|
|||||
|
2025
Q2 | $20.9K | Sell |
|
|||||
|
2025
Q1 | $367K | Sell |
|
|||||
|
2024
Q4 | $1.27M | Buy |
|
|||||
|
2024
Q3 | $149K | Sell |
|
|||||
|
2024
Q2 | $236K | Sell |
|
|||||
|
2024
Q1 | $259K | Sell |
|
|||||
|
2023
Q4 | $1.28M | Buy |
|
|||||
|
2023
Q3 | $901K | Sell |
|
|||||
|
2023
Q2 | $1.82M | Buy |
|
|||||
|
2023
Q1 | $135K | Sell |
|
|||||
|
2022
Q4 | $308K | Sell |
|
|||||
|
2022
Q3 | $575K | Sell |
|
|||||
|
2022
Q2 | $1.99M | Sell |
|
|||||
|
2022
Q1 | $2.31M | Buy |
|
|||||
|
2021
Q4 | $1.14M | Buy |
|
|||||
|
2021
Q3 | $169K | Sell |
|
|||||
|
2021
Q2 | $352K | Buy |
|
|||||
|
2021
Q1 | $181K | Sell |
|
|||||
|
2020
Q4 | $1.07M | Buy |
|
|||||
|
2020
Q3 | $631K | Buy |
|
|||||
|
2020
Q2 | $213K | Buy |
|
|||||
|
2020
Q1 | $3K | Sell |
|
|||||
|
2019
Q4 | $181K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $60K | Buy |
|
|||||
|
2019
Q1 | $14K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $113K | Buy |
|
|||||
|
2018
Q2 | $15K | Sell |
|
|||||
|
2018
Q1 | $663K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $61K | Buy |
|
|||||
|
2016
Q3 | $57K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $3K | Sell |
|
|||||
|
2015
Q4 | $28K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $47K | Buy |
|
|||||
|
2015
Q1 | $24K | Sell |
|
|||||
|
2014
Q4 | $45K | Sell |
|
|||||
|
2014
Q3 | $38K | Sell |
|
|||||
|
2014
Q2 | $79K | Sell |
|
|||||
|
2014
Q1 | $165K | Buy |
|
|||||
|
2013
Q4 | $32K | Sell |
|
|||||
|
2013
Q3 | $340K | Buy |
|
|||||
|
2013
Q2 | $23K | Buy |
|